drugset / Trial / NCT00473876

Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)

NCT00473876 ↗

Phase 4 Completed 62 enrolled University of Dundee
RandomizedParallel-groupDouble-blindTreatment

Summary

Will metformin improve exercise capacity in chronic heart failure patients who has insulin resistance (pre-diabetic- means before they become diabetic)?

Timeline

Start
2007-08
Primary completion
2009-04
Completion
2009-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 1000 mg —